Search
-
Clinical and pharmacological correlates of caffeine consumption in subjects with schizophrenia – Data from the FACE-SZ cohort
(Journal of Psychiatric Research. vol. 161, pp. 206-212, 2023-05-01)Article de revue -
3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort
(Progress in Neuro-Psychopharmacology and Biological Psychiatry. vol. 120, pp. 110641, 2023-01-10)Article de revue -
The puzzle of quality of life in schizophrenia: putting the pieces together with the FACE-SZ cohort
(Psychological Medicine. vol. 52, n° 8, pp. 1-8, 2020-09-23)Article de revue -
Relationships between neuropsychological performance, insight, medication adherence, and social metacognition in schizophrenia
Document de travail - Pré-publicationOpen access -
Immune Signatures of Treatment-Resistant Schizophrenia: A FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Study
(Schizophrenia Bulletin Open. vol. 2, n° 1, 2021-04-27)Article de revueOpen access -
Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ dataset.
(Translational Psychiatry. vol. 13, n° 1, pp. 341, 2023-11-07)Article de revueOpen access -
Major depression, sleep, hostility and body mass index are associated with impaired quality of life in schizophrenia. Results from the FACE-SZ cohort.
(Journal of Affective Disorders. vol. 274, pp. 617-623, 2020-09-01)Article de revueOpen access